In summary, ICA multi-targetedly regulates estrogen signaling, gut microbiota metabolism, OCN activity, and ALP function to reshape bone tissue energy metabolism homeostasis, offering novel targeted intervention strategies for metabolic disorder-associated osteoporosis. The gene discussed is BGLAP; the disease is osteoporosis.